Related references
Note: Only part of the references are listed.Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature
Antonio Raffone et al.
GYNECOLOGIC ONCOLOGY (2022)
Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms
Clelia Madeddu et al.
CANCERS (2022)
Not all stage I and II endometrial cancers are created equal: Recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy alone in all subgroups of early-stage high-intermediate and high-risk endometrial cancer
Simone Garzon et al.
GYNECOLOGIC ONCOLOGY (2022)
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021
Nadeem R. Abu-Rustum et al.
Journal of the National Comprehensive Cancer Network (2021)
Prediction of lymphovascular space invasion in patients with endometrial cancer
Sang Il Kim et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
Factors predicting recurrence in patients with stage IA endometrioid endometrial cancer: what is the importance of LVSI?
Isin Ureyen et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2020)
National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer
Rudy S. Suidan et al.
GYNECOLOGIC ONCOLOGY (2019)
Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy
Concetta Laliscia et al.
ONCOLOGY (2019)
Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer
Marcus E. Randall et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome
Yu-Jung Lin et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2019)
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2018)
Chemotherapy as Adjuvant Treatment for Early Stage Endometrial Cancer With High Intermediate Risk Factors
Min Gao et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Adjuvant Therapy in Early-Stage Endometrial Cancer: A Systematic Review of the Evidence, Guidelines, and Clinical Practice in the US
Nawar A. Latif et al.
ONCOLOGIST (2014)
Adjuvant chemotherapy for advanced endometrial cancer
Khadra Galaal et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality
D. J. O'Brien et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2009)
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial
R. Maggi et al.
BRITISH JOURNAL OF CANCER (2006)
Share Paper
